Probiotic Escherichia coli Nissle inhibits IL-6 and MAPK-mediated cardiac hypertrophy during STZ-induced diabetes in rats
Authors:
- 15 June 2021
- journal article
- research article
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- Vol. 12 (3) , 283-294
Abstract
Escherichia coliNissle (EcN), a probiotic bacterium protects against several disorders. Multiple reports have studied the pathways involved in cardiac hypertrophy. However, the effects of probiotic EcN against diabetes-induced cardiac hypertrophy remain to be understood. We administered five weeks old Wistar male (271±19.4 g body weight) streptozotocin-induced diabetic rats with 109cfu of EcN via oral gavage every day for 24 days followed by subjecting the rats to echocardiography to analyse the cardiac parameters. Overexpressed interleukin (IL)-6 induced the MEK5/ERK5, JAK2/STAT3, and MAPK signalling cascades in streptozotocin-induced diabetic rats. Further, the upregulation of calcineurin, NFATc3, and p-GATA4 led to the elevation of hypertrophy markers, such as atrial and B-type natriuretic peptides. In contrast, diabetic rats supplemented with probiotic EcN exhibited significant downregulated IL-6. Moreover, the MEK5/ERK5 and JAK2/STAT3 cascades involved during eccentric hypertrophy and MAPK signalling, including phosphorylated MEK, ERK, JNK, and p-38, were significantly attenuated in diabetic rats after supplementation of EcN. Western blotting and immunofluorescence revealed the significant downregulation of NFATc3 and downstream mediators, thereby resulting in the impairment of cardiac hypertrophy. Taken together, the findings demonstrate that supplementing probiotic EcN has the potential to show cardioprotective effects by inhibiting diabetes-induced cardiomyopathies.Keywords
This publication has 43 references indexed in Scilit:
- MicroRNAs Involved in the Mitogen-Activated Protein Kinase Cascades Pathway During Glucose-Induced Cardiomyocyte HypertrophyThe American Journal of Pathology, 2011
- Interrelationship Between Cardiac Hypertrophy, Heart Failure, and Chronic Kidney DiseaseCirculation Research, 2011
- Garlic Oil Alleviates MAPKs‐ and IL‐6‐mediated Diabetes‐related Cardiac Hypertrophy in STZ‐induced DM RatsEvidence-Based Complementary and Alternative Medicine, 2011
- Inhibition of growth of Shiga toxin-producingEscherichia coliby nonpathogenicEscherichia coliFEMS Microbiology Letters, 2009
- The non-pathogenicEscherichia colistrain Nissle 1917 – features of a versatile probioticMicrobial Ecology in Health and Disease, 2009
- Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy SettingPhysical Therapy, 2008
- Evidence of Increased Inflammation and Microcirculatory Abnormalities in Patients With Type 1 Diabetes and Their Role in Microvascular ComplicationsDiabetes, 2007
- Left ventricular geometric patterns in the Jackson cohort of the atherosclerotic risk in communities (ARIC) study: Clinical correlates and influences on systolic and diastolic dysfunctionAmerican Heart Journal, 2007
- Direct and Indirect Interactions between Calcineurin-NFAT and MEK1-Extracellular Signal-Regulated Kinase 1/2 Signaling Pathways Regulate Cardiac Gene Expression and Cellular GrowthMolecular and Cellular Biology, 2005
- The probioticEscherichia colistrain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogensFEMS Immunology & Medical Microbiology, 2004